Home›Search›MedComm

MedComm

John Wiley and Sons Inc · United States · Est. 1976

ISSN2688-2663eISSN2688-2663

SJR Q1✓ WOS ESCI✓ Scopus / SJR✓ DOAJ✓ Open Access

/ 100

Medium Risk

Score Breakdown

✓ WoS ESCI+10

✓ Scopus Q1+25

✓ DOAJ Verified+15

Total60

Journal Impact Factor

This journal is indexed in Web of Science (JCR) and has an official Journal Impact Factor. View the current value on the journal’s page ↗

SJR Score

2.469

H-Index

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIP

1.65

Total Works

1,547

Total Citations

24,675

2yr Mean Citedness

7.61

Free JIF alternative

Aims & Scope✦ Inferred from recent articles

MedComm publishes research on the biological and molecular underpinnings of diseases, including cancer, cardiovascular diseases, and liver failure. The journal focuses on understanding disease mechanisms through multi-omics analyses, spatial transcriptomics, and advanced imaging techniques. It also covers therapeutic innovations, such as bioartificial liver systems, natural product-derived drugs, and immune checkpoint inhibitors, as well as the role of epigenetics and RNA modifications in disease.

AI-summarised from recent articles · verify on publisher page →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

weeks to review

Fast · median is 15 wks

SJR Rank

Top 25% in field

General Information

Country / RegionUnited States

Primary LanguageEnglish

1st Year Published1976

FrequencyQuarterly

StatusActive (last: 2026)

Total Publications1,547

Publisher OrgWiley

Region🌍 Global South

OA Since2019

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

Review Time~10 weeks

Acceptance Rate—

OA LicenseCC BY

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

PorticoPMCCLOCKSS

Think.Check.Submit Compliance

thinkchecksubmit.org

10/12 · 83%

✅

Do you know the journal / publisher?

John Wiley and Sons Inc

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2688-2663 / 2688-2663

✅

Indexed in a trusted database?

Scopus, DOAJ

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

Portico, PMC, CLOCKSS

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Times cited

2014

2020

2021

2022

2023

2024

2025

2026

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Biochemistry (medical)Q1

Cell BiologyQ1

Drug DiscoveryQ1

GeneticsQ1

Genetics (clinical)Q1

Immunology and AllergyQ1

OncologyQ1

Subject Classification

Web of Science Categories

Medicine, Research & Experimental

Scopus Categories

GeneticsDrug DiscoveryBiochemistry (medical)Immunology and AllergyOncologyGenetics (clinical)Cell Biology

Research Topics (OpenAlex)

Immune cells in cancerRNA modifications and cancerCancer Immunotherapy and BiomarkersSARS-CoV-2 and COVID-19 ResearchEpigenetics and DNA MethylationImmune Cell Function and InteractionCancer-related molecular mechanisms researchFerroptosis and cancer prognosisMicroRNA in disease regulationCOVID-19 Clinical Research Studies